Trajan Group Holdings Ltd (TRJ) AI Stock Analysis

• Market Cap: AU$142.47M
• Dividend Yield: N/A
• Average Volume (3M): 21.82K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.26
• Revenue Growth: 7.38%
• EPS Growth: 82.39%
• Country: AU
• Employees: 600
• Sector: Healthcare
• Sector Strength: 47
• Industry: Medical - Instruments & Supplies
• EPS (TTM): >-0.01
• Shares Outstanding: 152,377,990
• 10 Day Avg. Volume: 18,302
• 30 Day Avg. Volume: 21,818
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: AU$1.23
• Price Target Upside: 30.85% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 2

• Rating: 52 Neutral
• Price Target: AU$1.00 ▲(6.38% Upside)

The overall stock score is influenced primarily by financial performance challenges, with declining revenues and profitability pressures being key concerns. Technical analysis provides some positive momentum, but weak valuation due to negative profitability significantly impacts the score.

Trajan Group Holdings Ltd Business Overview & Revenue Model

Company Description

Trajan Group Holdings Ltd (TRJ) is a leading provider in the analytical and life sciences sectors, specializing in the development, manufacture, and distribution of precision consumables and scientific instruments. The company focuses on enhancing scientific measurement capabilities, primarily serving the health, environment, and food industries. Trajan's core products include chromatography and mass spectrometry equipment, sample preparation devices, and other analytical tools that facilitate accurate scientific analysis and data collection.

How the Company Makes Money

Trajan Group Holdings Ltd generates revenue through the sale of its precision consumables and scientific instruments. The company's key revenue streams include direct sales to laboratories and research facilities, partnerships with scientific and healthcare organizations, and distribution agreements with global distributors. Trajan's growth is further supported by continuous innovation in product development and strategic acquisitions that expand its product offerings and market reach. The company also benefits from long-term relationships with clients in the health, environment, and food sectors, which demand consistent and high-quality analytical solutions.

Trajan Group Holdings Ltd Financial Statement Overview

Summary

Trajan Group Holdings Ltd faces financial challenges with declining revenues, negative net profit margin, and strained cash flow, raising liquidity concerns. The balance sheet shows moderate leverage, but net losses impact equity metrics.

Income Statement

The company experienced a decline in revenue in the most recent year, dropping from $162.2M to $155M. Gross profit margin decreased significantly from previous years, indicating cost pressures or reduced pricing power. The net profit margin turned negative, reflecting a loss position, which is concerning for profitability. The EBIT and EBITDA margins also worsened, further highlighting operational challenges.

Balance Sheet

The balance sheet shows moderate stability with a debt-to-equity ratio of 0.55 in 2024, indicating manageable leverage but a decrease from 2023. Stockholders' equity decreased, negatively affecting the equity ratio. However, the company's return on equity turned negative due to net losses, which is a notable downside.

Cash Flow

Operating cash flow showed slight stability, but the free cash flow decreased from the previous year. The operating cash flow to net income ratio suggests that cash generation is better than accounting income, which is a positive aspect. However, the overall cash flow situation is under pressure due to declining free cash flow, indicating potential liquidity risks.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	155.02M	162.15M	107.57M	76.57M	71.85M
Gross Profit	59.75M	22.93M	42.63M	28.48M	5.86M
EBITDA	-20.36M	14.86M	5.14M	3.46M	3.26M
Net Income	-25.33M	1.89M	1.70M	1.88M	2.62M
Balance Sheet
Total Assets	188.00M	229.04M	206.78M	99.38M	44.37M
Cash, Cash Equivalents and Short-Term Investments	11.24M	11.04M	13.16M	51.72M	4.79M
Total Debt	56.16M	61.30M	66.18M	17.02M	14.97M
Total Liabilities	85.15M	99.51M	90.27M	33.30M	26.63M
Stockholders Equity	102.85M	129.53M	116.51M	66.08M	17.74M
Cash Flow
Free Cash Flow	6.43M	998.00K	-1.28M	8.34M	964.00K
Operating Cash Flow	9.47M	9.55M	2.13M	9.45M	1.76M
Investing Cash Flow	-3.04M	-8.55M	-116.38M	402.00K	-797.00K
Financing Cash Flow	-6.40M	-3.36M	74.69M	36.81M	-236.00K

Trajan Group Holdings Ltd Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.94
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:TRJ, the sentiment is Positive. The current price of 0.94 is above the 20-day moving average (MA) of 0.92, above the 50-day MA of 0.82, and above the 200-day MA of 0.88, indicating a neutral trend. The MACD of 0.03 indicates Positive momentum. The RSI at 58.67 is Neutral, neither overbought nor oversold. The STOCH value of 78.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:TRJ.

Trajan Group Holdings Ltd Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
EZZ	77 Outperform	AU$116.52M	12.01	45.86%	1.62%	71.65%	152.89%
AHC	76 Outperform	AU$131.58M	22.09	12.35%	―	39.98%	-30.04%
TRJ	52 Neutral	AU$142.47M	―	-4.28%	―	7.38%	82.39%
Sector *	51 Neutral	$7.81B	-0.22	-40.01%	2.29%	21.48%	-2.11%
CYC	42 Neutral	AU$111.69M	―	-31.98%	―	34.20%	-23.90%
SHG	40 Underperform	AU$97.43M	―		―	―	―
ALA	40 Underperform	AU$106.45M	―	-47.98%	―	700.00%	26.88%

Trajan Group Holdings Ltd Corporate Events

Trajan Group Holdings Ltd Announces Cessation of Securities

Trajan Group Holdings Ltd has announced the cessation of 88,635 securities due to the lapse of conditional rights, as the conditions for these securities have not been met or have become incapable of being satisfied. This announcement may impact the company’s issued capital and could have implications for stakeholders regarding the company’s securities management.

The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.20 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.

Trajan Group Holdings Navigates Geopolitical Challenges with Strategic Resilience

Trajan Group Holdings Limited has announced its operational update, highlighting its resilience and agility in navigating the shifting geopolitical landscape. Despite challenges such as new tariffs and reduced US government funding, Trajan maintains its FY25 revenue guidance, expecting growth of at least 3% over the prior year. The company is expanding its regional manufacturing capabilities to mitigate risks and enhance supply chain resilience, while also deepening relationships with global customers. Although there is some risk to achieving nEBITDA guidance due to margin performance, Trajan remains confident in its strategy and ability to manage through complexity.

The most recent analyst rating on (AU:TRJ) stock is a Buy with a A$1.20 price target. To see the full list of analyst forecasts on Trajan Group Holdings Ltd stock, see the AU:TRJ Stock Forecast page.